CUR-101

N/A

Report date: 2025/06/16 16:57:41
First In Class

Base Information

Drug NameCUR-101
Drug Alias NameCUR-101
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCycuria Therapeutics GmbH
China Registration ClassN/A

Develop Information

Active CompaniesCycuria Therapeutics GmbH
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A